milrinone has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To characterize the effect of the phosphodiesterase inhibitor (PDEI) milrinone in adult patients with a non-hyperdynamic condition during the course of the systemic inflammatory response syndrome (SIRS) or sepsis when compared with patients with congestive heart failure (CHF)." | 9.09 | IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. ( Delle Karth, G; Frossard, M; Geppert, A; Gschwandtner, ME; Heinz, G; Neunteufl, T; Reinelt, P; Siostrzonek, P; Zauner, C, 1999) |
| "To characterize the effect of the phosphodiesterase inhibitor (PDEI) milrinone in adult patients with a non-hyperdynamic condition during the course of the systemic inflammatory response syndrome (SIRS) or sepsis when compared with patients with congestive heart failure (CHF)." | 5.09 | IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. ( Delle Karth, G; Frossard, M; Geppert, A; Gschwandtner, ME; Heinz, G; Neunteufl, T; Reinelt, P; Siostrzonek, P; Zauner, C, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blink, M | 1 |
| Buddingh', EP | 1 |
| Filippini, LHPM | 1 |
| Brinkman, DMC | 1 |
| Joosten, SA | 1 |
| Klein, RH | 1 |
| Seri, I | 1 |
| Noori, S | 1 |
| Heinz, G | 1 |
| Geppert, A | 1 |
| Delle Karth, G | 1 |
| Reinelt, P | 1 |
| Gschwandtner, ME | 1 |
| Neunteufl, T | 1 |
| Zauner, C | 1 |
| Frossard, M | 1 |
| Siostrzonek, P | 1 |
| Hayashida, N | 1 |
| Tomoeda, H | 1 |
| Oda, T | 1 |
| Tayama, E | 1 |
| Chihara, S | 1 |
| Kawara, T | 1 |
| Aoyagi, S | 1 |
1 review available for milrinone and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Diagnosis and treatment of neonatal hypotension outside the transitional period.
Topics: Adrenal Insufficiency; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, | 2005 |
2 trials available for milrinone and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mil | 1999 |
Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass.
Topics: Aged; Coronary Artery Bypass; Creatine Kinase; Cyclic AMP; Cytokines; Female; Hemodynamics; Humans; | 1999 |
1 other study available for milrinone and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].
Topics: Adolescent; Anti-Inflammatory Agents; Aspirin; Cardiotonic Agents; COVID-19; COVID-19 Serological Te | 2020 |